The Pharmaceutical industry is constantly looking at ways to drive cost from its supply chain whilst recognising the need for robust customer service, high quality product and overall compliance.
Our client is looking to reduce the cost base of its finishing and packaging operations where an aggressive target has been set to remove up to $180m from the gross margin.
It has been recognised that adopting a continuous improvement methodology will not work in isolation. The team is therefore challenged to explore all supply chain strategies that may be able to deliver the benefit required whilst providing high levels of customer service to partners in their development and commercial groups.
We formed a cross functional team bringing together experts in supply chain and regulatory affairs, with backgrounds within and external to the pharmaceutical industry. The team has worked through a rapid and proven process to:
Our research and analysis from across the pharmaceutical industry and other cost sensitive industries has provided our client with a platform to develop various strategic models. The output of this activity also included a peer review of pharmaceutical finishing and packaging strategies and a review of supply chain techniques from other industries to address margin erosion.
The accelerated solution design provided our client with the correct environment to build these strategic models, discuss options and challenge the status quo.